FDA approves Cosette Pharmaceuticals' EVOXAC

– – New Oral Solution Formulation Developed for Patients Living with Sjögren’s Disease demonstrates Cosette's expanding capabilities in product development and innovation – –

– – Product Expected to be Commercially Available by the end of 2026 – –